|
Amgen Common
(AMGN)
|
5.5 |
$144M |
|
612k |
235.86 |
|
Vertex Pharmaceuticals Common
(VRTX)
|
5.3 |
$139M |
|
477k |
290.31 |
|
Gilead Sciences Common
(GILD)
|
4.6 |
$122M |
|
1.6M |
76.94 |
|
Regeneron Pharmaceuticals Common
(REGN)
|
4.5 |
$117M |
|
188k |
623.65 |
|
Johnson & Johnson Common
(JNJ)
|
4.4 |
$117M |
|
830k |
140.63 |
|
Unitedhealth Group Common
(UNH)
|
3.1 |
$83M |
|
280k |
294.95 |
|
Illumina Common
(ILMN)
|
3.0 |
$80M |
|
215k |
370.35 |
|
Merck & Co Common
(MRK)
|
2.9 |
$75M |
|
972k |
77.33 |
|
Biogen Common
(BIIB)
|
2.4 |
$63M |
|
234k |
267.55 |
|
Bristol-Myers Squibb Common
(BMY)
|
2.2 |
$58M |
|
978k |
58.80 |
|
Pfizer Common
(PFE)
|
2.1 |
$54M |
|
1.7M |
32.70 |
|
AbbVie Common
(ABBV)
|
2.0 |
$52M |
|
534k |
98.18 |
|
CVS Health Corp. Common
(CVS)
|
1.8 |
$47M |
|
720k |
64.97 |
|
Abbott Laboratories Common
(ABT)
|
1.7 |
$45M |
|
486k |
91.43 |
|
Medtronic Shares
(MDT)
|
1.7 |
$44M |
|
476k |
91.70 |
|
Alexion Pharmaceuticals Common
|
1.6 |
$43M |
|
385k |
112.24 |
|
Seattle Genetics Common
|
1.6 |
$41M |
|
241k |
169.92 |
|
Thermo Fisher Scientific Common
(TMO)
|
1.5 |
$38M |
|
106k |
362.34 |
|
Eli Lilly and Common
(LLY)
|
1.3 |
$34M |
|
207k |
164.18 |
|
Incyte Corp. Common
(INCY)
|
1.3 |
$34M |
|
325k |
103.97 |
|
Moderna Common
(MRNA)
|
1.2 |
$32M |
|
493k |
64.21 |
|
BioMarin Pharmaceutical Common
(BMRN)
|
1.2 |
$30M |
|
245k |
123.34 |
|
Stryker Corp. Common
(SYK)
|
1.1 |
$30M |
|
164k |
180.19 |
|
Danaher Corp. Common
(DHR)
|
1.1 |
$28M |
|
159k |
176.83 |
|
Neurocrine Biosciences Common
(NBIX)
|
1.0 |
$25M |
|
206k |
122.00 |
|
Horizon Therapeutics Shares
|
0.9 |
$23M |
|
410k |
55.58 |
|
Boston Scientific Corp. Common
(BSX)
|
0.9 |
$23M |
|
645k |
35.11 |
|
Sarepta Therapeutics Common
(SRPT)
|
0.9 |
$23M |
|
140k |
160.34 |
|
Exelixis Common
(EXEL)
|
0.8 |
$22M |
|
934k |
23.74 |
|
Intuitive Surgical Common
(ISRG)
|
0.7 |
$19M |
|
33k |
569.84 |
|
Humana Common
(HUM)
|
0.7 |
$19M |
|
49k |
387.75 |
|
Alnylam Pharmaceuticals Common
(ALNY)
|
0.7 |
$19M |
|
126k |
148.11 |
|
Becton, Dickinson and Common
(BDX)
|
0.7 |
$19M |
|
78k |
239.27 |
|
Centene Corp. Common
(CNC)
|
0.7 |
$18M |
|
288k |
63.55 |
|
Immunomedics Common
|
0.7 |
$18M |
|
497k |
35.44 |
|
Sanofi Sponsored ADR
(SNY)
|
0.6 |
$17M |
|
327k |
51.05 |
|
McKesson Corp. Common
(MCK)
|
0.6 |
$17M |
|
108k |
153.42 |
|
Mylan Shares
|
0.6 |
$16M |
|
1.0M |
16.08 |
|
Cigna Corp. Common
(CI)
|
0.6 |
$15M |
|
80k |
187.65 |
|
Novartis Sponsored ADR
(NVS)
|
0.6 |
$15M |
|
171k |
87.34 |
|
BeiGene Sponsored ADR
(ONC)
|
0.5 |
$14M |
|
75k |
188.40 |
|
Edwards Lifesciences Corp. Common
(EW)
|
0.5 |
$14M |
|
202k |
69.11 |
|
PRA Health Sciences Common
|
0.5 |
$14M |
|
144k |
97.29 |
|
Bio-Techne Corp. Common
(TECH)
|
0.5 |
$14M |
|
52k |
264.07 |
|
AstraZeneca Sponsored ADR
(AZN)
|
0.5 |
$12M |
|
235k |
52.89 |
|
IDEXX Laboratories Common
(IDXX)
|
0.5 |
$12M |
|
37k |
330.17 |
|
ACADIA Pharmaceuticals Common
(ACAD)
|
0.5 |
$12M |
|
251k |
48.47 |
|
IQVIA Holdings Common
(IQV)
|
0.4 |
$12M |
|
82k |
141.88 |
|
Ionis Pharmaceuticals Common
(IONS)
|
0.4 |
$11M |
|
193k |
58.96 |
|
Zimmer Biomet Holdings Common
(ZBH)
|
0.4 |
$11M |
|
95k |
119.36 |
|
Zoetis Class A
(ZTS)
|
0.4 |
$11M |
|
81k |
137.04 |
|
Anthem Common
(ELV)
|
0.4 |
$11M |
|
40k |
262.98 |
|
Welltower Common
(WELL)
|
0.4 |
$11M |
|
203k |
51.75 |
|
Baxter International Common
(BAX)
|
0.4 |
$11M |
|
122k |
86.10 |
|
argenx SE Sponsored ADR
(ARGX)
|
0.4 |
$10M |
|
45k |
225.23 |
|
Agios Pharmaceuticals Common
(AGIO)
|
0.4 |
$10M |
|
187k |
53.48 |
|
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.4 |
$9.7M |
|
786k |
12.33 |
|
Allogene Therapeutics Common
(ALLO)
|
0.4 |
$9.3M |
|
216k |
42.82 |
|
Blueprint Medicines Corp. Common
(BPMC)
|
0.4 |
$9.2M |
|
118k |
78.00 |
|
Omega Healthcare Investors Common
(OHI)
|
0.3 |
$9.1M |
|
306k |
29.73 |
|
Mirati Therapeutics Common
|
0.3 |
$9.0M |
|
79k |
114.17 |
|
GlaxoSmithKline Shares
|
0.3 |
$9.0M |
|
220k |
40.79 |
|
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.3 |
$8.8M |
|
134k |
65.48 |
|
Physicians Realty Trust Common
|
0.3 |
$8.7M |
|
496k |
17.52 |
|
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.3 |
$8.5M |
|
58k |
147.91 |
|
HCA Healthcare Common
(HCA)
|
0.3 |
$8.1M |
|
84k |
97.06 |
|
AmerisourceBergen Corp. Common
(COR)
|
0.3 |
$8.1M |
|
81k |
100.78 |
|
Reata Pharmaceuticals Class A
|
0.3 |
$7.9M |
|
51k |
156.03 |
|
FibroGen Common
|
0.3 |
$7.9M |
|
194k |
40.53 |
|
Laboratory Corporation of America Holdings Sponsored ADR
|
0.3 |
$7.8M |
|
47k |
166.11 |
|
NovoCure Ordinary Shares
(NVCR)
|
0.3 |
$7.8M |
|
132k |
59.30 |
|
Medical Properties Trust Common
(MPW)
|
0.3 |
$7.7M |
|
412k |
18.80 |
|
United Therapeutics Corp. Class B
(UTHR)
|
0.3 |
$7.7M |
|
64k |
121.00 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.3 |
$7.6M |
|
98k |
78.22 |
|
Ventas Common
(VTR)
|
0.3 |
$7.6M |
|
208k |
36.62 |
|
Atreca Class A Common
(BCEL)
|
0.3 |
$7.5M |
|
352k |
21.28 |
|
Jazz Pharmaceuticals Shares
(JAZZ)
|
0.3 |
$7.4M |
|
68k |
110.34 |
|
Iovance Biotherapeutics Common
(IOVA)
|
0.3 |
$7.4M |
|
271k |
27.45 |
|
Galera Therapeutics Common
(GRTX)
|
0.3 |
$7.4M |
|
1.0M |
7.14 |
|
Sabra Health Care REIT Common
(SBRA)
|
0.3 |
$7.4M |
|
511k |
14.43 |
|
Dentsply Sirona Common
(XRAY)
|
0.3 |
$7.1M |
|
161k |
44.06 |
|
LTC Properties Common
(LTC)
|
0.3 |
$6.9M |
|
182k |
37.67 |
|
Waters Corporation Common
(WAT)
|
0.3 |
$6.7M |
|
37k |
180.40 |
|
Guardant Health Common
(GH)
|
0.3 |
$6.6M |
|
81k |
81.13 |
|
Fate Therapeutics Common
(FATE)
|
0.2 |
$6.4M |
|
186k |
34.31 |
|
Syneos Health Class A
|
0.2 |
$6.3M |
|
108k |
58.25 |
|
Teleflex Common
(TFX)
|
0.2 |
$6.3M |
|
17k |
363.96 |
|
PTC Therapeutics Common
(PTCT)
|
0.2 |
$6.1M |
|
121k |
50.74 |
|
Nektar Therapeutics Common
|
0.2 |
$6.1M |
|
263k |
23.16 |
|
Rocket Pharmaceuticals Common
(RCKT)
|
0.2 |
$6.0M |
|
289k |
20.93 |
|
Amarin Corporation Sponsored ADR
|
0.2 |
$5.9M |
|
850k |
6.92 |
|
Zogenix Common
|
0.2 |
$5.8M |
|
215k |
27.01 |
|
Apellis Pharmaceuticals Common
(APLS)
|
0.2 |
$5.7M |
|
174k |
32.66 |
|
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.2 |
$5.6M |
|
76k |
73.50 |
|
Cerner Corp. Common
|
0.2 |
$5.6M |
|
82k |
68.55 |
|
Arena Pharmaceuticals Common
|
0.2 |
$5.5M |
|
88k |
62.95 |
|
Inovio Pharmaceuticals Common
|
0.2 |
$5.4M |
|
202k |
26.95 |
|
Bristol-Myers Squibb Right
|
0.2 |
$5.3M |
|
1.5M |
3.58 |
|
bluebird bio Common
|
0.2 |
$5.1M |
|
84k |
61.04 |
|
Amicus Therapeutics Common
(FOLD)
|
0.2 |
$5.1M |
|
337k |
15.08 |
|
Sutro Biopharma Common
(STRO)
|
0.2 |
$5.0M |
|
641k |
7.76 |
|
Mettler-Toledo International Common
(MTD)
|
0.2 |
$4.9M |
|
6.1k |
805.49 |
|
Molina Healthcare Common
(MOH)
|
0.2 |
$4.9M |
|
28k |
177.99 |
|
Theravance Biopharma Common
(TBPH)
|
0.2 |
$4.8M |
|
229k |
20.99 |
|
Xencor Common
(XNCR)
|
0.2 |
$4.8M |
|
148k |
32.39 |
|
Agilent Technologies Common
(A)
|
0.2 |
$4.6M |
|
53k |
88.38 |
|
Allakos Common
|
0.2 |
$4.6M |
|
64k |
71.87 |
|
Global Blood Therapeutics Common
|
0.2 |
$4.5M |
|
72k |
63.13 |
|
Pieris Pharmaceuticals Common
|
0.2 |
$4.5M |
|
1.4M |
3.10 |
|
Ardelyx Common
(ARDX)
|
0.2 |
$4.2M |
|
608k |
6.92 |
|
Healthpeak Properties Common
(DOC)
|
0.2 |
$4.1M |
|
150k |
27.56 |
|
Sage Therapeutics Common
(SAGE)
|
0.2 |
$4.0M |
|
96k |
41.58 |
|
Acceleron Pharma Common
|
0.1 |
$3.9M |
|
41k |
95.28 |
|
Amedisys Common
(AMED)
|
0.1 |
$3.9M |
|
19k |
198.56 |
|
Editas Medicine Common
(EDIT)
|
0.1 |
$3.9M |
|
130k |
29.58 |
|
Exact Sciences Corp. Common
(EXAS)
|
0.1 |
$3.8M |
|
44k |
86.95 |
|
Abiomed Common
|
0.1 |
$3.8M |
|
16k |
241.55 |
|
Smith & Nephew Shares
(SNN)
|
0.1 |
$3.8M |
|
100k |
38.12 |
|
PerkinElmer Common
(RVTY)
|
0.1 |
$3.8M |
|
39k |
98.09 |
|
Takeda Pharmaceutical Company Sponsored ADS
(TAK)
|
0.1 |
$3.8M |
|
210k |
17.93 |
|
Momenta Pharmaceuticals Common
|
0.1 |
$3.7M |
|
112k |
33.27 |
|
Intercept Pharmaceuticals Common
|
0.1 |
$3.7M |
|
77k |
47.91 |
|
Deciphera Pharmaceuticals Common
|
0.1 |
$3.7M |
|
61k |
59.72 |
|
Coherus Biosciences Common
(CHRS)
|
0.1 |
$3.6M |
|
203k |
17.86 |
|
Trillium Therapeutics Common
|
0.1 |
$3.6M |
|
448k |
8.09 |
|
Principia Biopharma Common
|
0.1 |
$3.6M |
|
60k |
59.79 |
|
ResMed Common
(RMD)
|
0.1 |
$3.4M |
|
18k |
192.03 |
|
Ligand Pharmaceuticals Common
(LGND)
|
0.1 |
$3.4M |
|
31k |
111.83 |
|
Epizyme Common
|
0.1 |
$3.3M |
|
208k |
16.06 |
|
Karuna Therapeutics Common
|
0.1 |
$3.3M |
|
30k |
111.47 |
|
Y-mAbs Therapeutics Common
|
0.1 |
$3.3M |
|
77k |
43.20 |
|
Alkermes Shares
(ALKS)
|
0.1 |
$3.3M |
|
170k |
19.40 |
|
Acadia Healthcare Company Common
(ACHC)
|
0.1 |
$3.3M |
|
131k |
25.12 |
|
Charles River Laboratories International Common
(CRL)
|
0.1 |
$3.2M |
|
19k |
174.37 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.1 |
$3.2M |
|
74k |
43.19 |
|
Corbus Pharmaceuticals Holdings Common
|
0.1 |
$3.2M |
|
379k |
8.39 |
|
Zai Lab Adr
(ZLAB)
|
0.1 |
$3.1M |
|
38k |
82.14 |
|
GW Pharmaceuticals Ads
|
0.1 |
$3.1M |
|
25k |
122.71 |
|
Quotient Common
|
0.1 |
$3.0M |
|
412k |
7.40 |
|
Healthcare Realty Trust Common
|
0.1 |
$3.0M |
|
104k |
29.29 |
|
DexCom Common
(DXCM)
|
0.1 |
$2.9M |
|
7.3k |
405.46 |
|
uniQure Shares
(QURE)
|
0.1 |
$2.8M |
|
63k |
45.07 |
|
Perrigo Company Shares
(PRGO)
|
0.1 |
$2.8M |
|
51k |
55.27 |
|
Align Technology Common
(ALGN)
|
0.1 |
$2.8M |
|
10k |
274.47 |
|
Ovid Therapeutics Sponsored ADR
(OVID)
|
0.1 |
$2.7M |
|
373k |
7.37 |
|
Insmed Common
(INSM)
|
0.1 |
$2.7M |
|
98k |
27.54 |
|
AnaptysBio Common
(ANAB)
|
0.1 |
$2.6M |
|
118k |
22.34 |
|
Koninklijke Philips NY Reg Sh
(PHG)
|
0.1 |
$2.6M |
|
56k |
46.83 |
|
Axsome Therapeutics Common
(AXSM)
|
0.1 |
$2.6M |
|
32k |
82.27 |
|
Biohaven Pharmaceutical Holding Company Common
|
0.1 |
$2.5M |
|
34k |
73.11 |
|
Avrobio Common
(AVRO)
|
0.1 |
$2.5M |
|
141k |
17.45 |
|
Intra-Cellular Therapies Common
(ITCI)
|
0.1 |
$2.4M |
|
94k |
25.67 |
|
Quest Diagnostics Common
(DGX)
|
0.1 |
$2.4M |
|
21k |
113.96 |
|
Novavax Common
(NVAX)
|
0.1 |
$2.4M |
|
29k |
83.36 |
|
Bausch Health Companies Common
(BHC)
|
0.1 |
$2.2M |
|
118k |
18.29 |
|
Esperion Therapeutics Common
(ESPR)
|
0.1 |
$2.1M |
|
42k |
51.30 |
|
Alcon Ordinary Shares
(ALC)
|
0.1 |
$2.1M |
|
37k |
57.32 |
|
Revance Therapeutics Common
|
0.1 |
$2.1M |
|
86k |
24.42 |
|
Zymeworks Common
|
0.1 |
$2.0M |
|
56k |
36.08 |
|
Global Medical REIT Common
|
0.1 |
$2.0M |
|
175k |
11.33 |
|
Portola Pharmaceuticals Sponsored ADR
|
0.1 |
$2.0M |
|
109k |
17.99 |
|
Cellectis Sponsored ADR
(CLLS)
|
0.1 |
$2.0M |
|
110k |
17.80 |
|
Heron Therapeutics Common
(HRTX)
|
0.1 |
$1.9M |
|
131k |
14.71 |
|
Avadel Pharmaceuticals Sponsored ADR
|
0.1 |
$1.9M |
|
234k |
8.08 |
|
Halozyme Therapeutics Common
(HALO)
|
0.1 |
$1.9M |
|
70k |
26.80 |
|
Healthcare Trust of America Common
|
0.1 |
$1.9M |
|
71k |
26.52 |
|
MyoKardia Common
|
0.1 |
$1.9M |
|
19k |
96.63 |
|
Hologic Common
(HOLX)
|
0.1 |
$1.9M |
|
33k |
57.00 |
|
Inogen Common
(INGN)
|
0.1 |
$1.8M |
|
51k |
35.52 |
|
Endo International Shares
|
0.1 |
$1.8M |
|
532k |
3.43 |
|
Medpace Holdings Common
(MEDP)
|
0.1 |
$1.8M |
|
19k |
93.00 |
|
Tenet Healthcare Corp. Common
(THC)
|
0.1 |
$1.8M |
|
97k |
18.11 |
|
Steris Shares
(STE)
|
0.1 |
$1.7M |
|
11k |
153.41 |
|
Pacific Biosciences of California Common
(PACB)
|
0.1 |
$1.7M |
|
496k |
3.45 |
|
Evolent Health Common
(EVH)
|
0.1 |
$1.6M |
|
231k |
7.12 |
|
Diversified Healthcare Trust Common
(DHC)
|
0.1 |
$1.6M |
|
358k |
4.43 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
0.1 |
$1.5M |
|
13k |
113.27 |
|
Addus HomeCare Corp. Common
(ADUS)
|
0.1 |
$1.5M |
|
16k |
92.55 |
|
Aurinia Pharmaceuticals Common
(AUPH)
|
0.1 |
$1.5M |
|
91k |
16.25 |
|
Magenta Therapeutics Common
|
0.1 |
$1.4M |
|
192k |
7.51 |
|
Assertio Holdings Common
|
0.1 |
$1.4M |
|
1.6M |
0.86 |
|
Tricida Common
|
0.1 |
$1.4M |
|
50k |
27.48 |
|
Sangamo Therapeutics Common
(SGMO)
|
0.1 |
$1.3M |
|
150k |
8.96 |
|
WaVe Life Sciences Shares
(WVE)
|
0.1 |
$1.3M |
|
128k |
10.41 |
|
Galapagos NV Sponsored ADR
(GLPG)
|
0.0 |
$1.3M |
|
6.5k |
197.31 |
|
BridgeBio Pharma Common
(BBIO)
|
0.0 |
$1.3M |
|
39k |
32.60 |
|
Kodiak Sciences Common
(KOD)
|
0.0 |
$1.3M |
|
23k |
54.12 |
|
Verona Pharma Sponsored ADR
(VRNA)
|
0.0 |
$1.2M |
|
253k |
4.67 |
|
Intellia Therapeutics Common
(NTLA)
|
0.0 |
$1.2M |
|
55k |
21.02 |
|
AC Immune SA Shares
(ACIU)
|
0.0 |
$1.2M |
|
172k |
6.73 |
|
Health Care Select Sector SPDR Fund SBI Healthcare
(XLV)
|
0.0 |
$1.0M |
|
10k |
100.05 |
|
Axonics Modulation Technologies Common
(AXNX)
|
0.0 |
$987k |
|
28k |
35.12 |
|
Aerie Pharmaceuticals Common
|
0.0 |
$984k |
|
67k |
14.76 |
|
Eidos Therapeutics Common
|
0.0 |
$953k |
|
20k |
47.65 |
|
Menlo Therapeutics Common
|
0.0 |
$937k |
|
542k |
1.73 |
|
Rubius Therapeutics Common
|
0.0 |
$933k |
|
156k |
5.98 |
|
New Senior Investment Group Common
|
0.0 |
$928k |
|
256k |
3.62 |
|
Universal Health Realty Income Trust Shares
(UHT)
|
0.0 |
$895k |
|
11k |
79.50 |
|
Grifols Sponsored ADR
(GRFS)
|
0.0 |
$864k |
|
47k |
18.24 |
|
Innate Pharma SA Sponsored ADS
|
0.0 |
$858k |
|
138k |
6.23 |
|
Milestone Pharmaceuticals Common
(MIST)
|
0.0 |
$806k |
|
213k |
3.78 |
|
Regenxbio Common
(RGNX)
|
0.0 |
$799k |
|
22k |
36.82 |
|
ImmunoGen Common
|
0.0 |
$774k |
|
168k |
4.60 |
|
Puma Biotechnology Common
(PBYI)
|
0.0 |
$744k |
|
71k |
10.43 |
|
Cidara Therapeutics Common
|
0.0 |
$720k |
|
195k |
3.69 |
|
MorphoSys Sponsored ADS
(MOR)
|
0.0 |
$614k |
|
19k |
31.67 |
|
National Health Investors Common
(NHI)
|
0.0 |
$610k |
|
10k |
60.77 |
|
Community Healthcare Trust Common
(CHCT)
|
0.0 |
$609k |
|
15k |
40.87 |
|
Molecular Templates Common
|
0.0 |
$583k |
|
42k |
13.78 |
|
Genmab A/S Sponsored ADS
(GMAB)
|
0.0 |
$560k |
|
17k |
33.90 |
|
Spectrum Pharmaceuticals Common
|
0.0 |
$388k |
|
115k |
3.38 |
|
Turning Point Therapeutics Common
|
0.0 |
$367k |
|
5.7k |
64.65 |
|
Community Health Systems Common
(CYH)
|
0.0 |
$354k |
|
118k |
3.01 |
|
Aerpio Pharmaceuticals Common
|
0.0 |
$322k |
|
258k |
1.25 |
|
Clearside Biomedical Common
(CLSD)
|
0.0 |
$311k |
|
165k |
1.88 |
|
CymaBay Therapeutics Common
|
0.0 |
$307k |
|
88k |
3.48 |
|
ARCA biopharma Common
(ABIO)
|
0.0 |
$215k |
|
33k |
6.62 |
|
Tetraphase Pharmaceuticals Common
|
0.0 |
$108k |
|
43k |
2.51 |
|
Five Star Senior Living Common
|
0.0 |
$95k |
|
24k |
3.92 |
|
Celldex Therapeutics Common
(CLDX)
|
0.0 |
$92k |
|
7.1k |
13.04 |
|
Mallinckrodt Sponsored ADR
|
0.0 |
$88k |
|
33k |
2.67 |
|
Bellicum Pharmaceuticals Common
|
0.0 |
$45k |
|
6.0k |
7.50 |